BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 21514067)

  • 1. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
    Martins EB; Chojniak R; Kowalski LP; Nicolau UR; Lima EN; Bitencourt AG
    PLoS One; 2015; 10(11):e0140009. PubMed ID: 26562784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
    Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
    J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
    Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cervical lymph-nodes using a multi-parametric and multi-modal approach for an early prediction of tumor response to chemo-radiotherapy.
    Scalco E; Marzi S; Sanguineti G; Vidiri A; Rizzo G
    Phys Med; 2016 Dec; 32(12):1672-1680. PubMed ID: 27639451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging.
    Marzi S; Piludu F; Sanguineti G; Marucci L; Farneti A; Terrenato I; Pellini R; Benevolo M; Covello R; Vidiri A
    Eur J Radiol; 2017 Jul; 92():93-102. PubMed ID: 28624026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
    Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
    Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
    Clavel S; Charron MP; Bélair M; Delouya G; Fortin B; Després P; Soulières D; Filion E; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):567-73. PubMed ID: 21310545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
    Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
    Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
    Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
    Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
    Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
    Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
    Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
    Makino H; Kato H; Furui T; Morishige K; Kanematsu M
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy.
    Liu G; Yang Z; Li T; Yang L; Zheng X; Cai L
    J Cancer Res Ther; 2017; 13(5):748-755. PubMed ID: 29237898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review.
    Chung SR; Choi YJ; Suh CH; Lee JH; Baek JH
    Korean J Radiol; 2019 Apr; 20(4):649-661. PubMed ID: 30887747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.